Project Grant HT94252310488

The Mayo Clinic was awarded a $1,605,726.00 Cooperative Agreement from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to provide treatment of pulmonary insults from acute and chronic toxic exposures using purified exosome products. The project aims to investigate medical solutions for the battlefield through innovative and impactful research focused on transforming health care for Service Members and the American public. The 3-year project...

The Department of Defense's Defense Health Agency awarded a $322,800 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Mayo Clinic in Rochester, Minnesota. The grant, with a performance period from April 1, 2024 to March 31, 2026, supports research on "MYELOPEROXIDASE PROMOTES PERSISTENT FIBROSIS." As a renowned non-profit academic medical center, Mayo Clinic will leverage its expertise in clinical care, biomedical research, and medical...

The U.S. Defense Health Agency has awarded a $1,187,875 Project Grant to Mayo Clinic to support the research project "INVESTIGATING MOLECULAR MECHANISMS UNDERLYING THE CILIARY TRAFFICKING OF POLYCYSTINS". This grant, awarded on April 1, 2024 under the Military Medical Research and Development program (CFDA 12.420), will fund research to advance the understanding of the molecular mechanisms involved in the trafficking of polycystins through cellular cilia. The project aims to yield...

The Mayo Clinic was awarded a $1.7 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research...

The Mayo Clinic received a $278,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions...

Mayo Clinic will receive $795,000 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct the project "PHARMACODYNAMIC BIOMARKER-GUIDED METABOLIC COLLAPSE OF IDH-MUTANT GLIOMA" from September 2021 through September 2024. This Project Grant aims to develop medical solutions for the battlefield by investigating pharmacodynamic biomarkers to guide targeted metabolic therapies for the treatment of isocitrate...

The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...

This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to Mayo Clinic provides $1,443,639.00 to investigate the molecular mechanisms underlying the ciliary trafficking of polycystins. The grant has an award date of April 1, 2024 and a planned completion date of March 31, 2028. This research seeks to advance the understanding of diseases related to ciliary dysfunction, which may have important implications for military medicine....

The Defense Health Agency awarded a $1,210,500.00 Project Grant to Mayo Clinic under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, with a performance period from April 1, 2025 to March 31, 2028, supports research exploring novel biomarkers for amyotrophic lateral sclerosis (ALS) using a multiomics approach. The research involves immunoprofiling, extracellular vesicle analysis, and TDP-43 aggregation assays to identify potential diagnostic and...

The Defense Health Agency awarded a $597,543.00 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, a nonprofit academic medical center. The grant, which runs from October 1, 2023 to September 14, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420) to support research aimed at "elucidating mechanisms of CAR-T cell immunotherapy resistance and sensitivity to improve treatment of myeloma." As a nonprofit organization with...